MDT

Medtronic plc

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$5.0bn31-Jul-2610-Q filed 03-Sep-26
Remaining authorization$958m31-Jul-2610-Q filed 03-Sep-26
Program expiryn/a—
Repurchased last quarter$226m31-Jul-2610-Q filed 03-Sep-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
Not found in filings$5.0bn$958mn/aIn March 2024, the Company's Board of Directors authorized the repurchase of $5.0 billion of the Company's ordinary shares. There is no specific time period associated with these repurchase authorizations.10-Q filed 03-Sep-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. May ’26
  2. ≈$100m
    Jul ’26
  3. ≈$85m
    Jul ’26
Month endedSharesAvg price≈ ValueSource
31-Jul-261,017,165$83.24$85m10-Q filed 03-Sep-26
03-Jul-261,246,200$80.54$100m10-Q filed 03-Sep-26
29-May-26502,144$80.67$41m10-Q filed 03-Sep-26
Filings through 31-Jul-26· checked 23-Sep-26